Singling Out RNA Biomarkers in Situ
ACD’s ISH Platform Achieves Single-Base Resolution and Retains Morphological Context
Microanalyte MDx Goes Mainstream
Nucleic Acid Analytes Are Reliable Sources of Data for Diagnostic Calculations
Continuous Bioprocessing Skips a Beat
Bioprocessing Needs a Tuneup If It Is to Run Smoothly and At Full Power
Counting on Faster Flow Cytometry
In Flow Cytometry, “Fast” Is About Speedily Collecting and Analyzing Data
For full access to this article login to GEN Select now.
Cell-Based Assay R&D Role Expands
Automation, Label-Free Tools, and Other Innovations Create Better Screening
- Cell-based assays have become a quick, lower-cost means of testing drug candidates for toxic effects in early discovery work. Informa Life Sciences’ upcoming “Cell-Based Assays” meeting will highlight some advances that are driving the field such as improved screening technologies, noninvasive monitoring, and the increasingly important incorporation of automation. ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.